"With the approval of Journavx, a non-opioid, pain signal inhibitor and the first new class of pain medicine approved in more than 20 years, we have the opportunity to change the paradigm of acute ...

It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the medication intended to improve their life. It’s left both healthcare ...